The role of solid state characterization in predicting stability of solid dosage forms

Péter Szabó, R. Zelkó, I. Antal

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Stability of a dosage form is its ability to preserve its quality attributes within preset limits. The time span over which these attributes remain within specifications is the shelf-life of the drug product. Stability is a very complex feature and is influenced not only by the stability of the drug substance but also by the stability of excipients and the interaction of the components within the system. Another important contributing factor is the packaging material, which is responsible for the protection of the drug product. Not only drug substances, but also excipients are susceptible to different degradation mechanisms. Amorphous polymers, a relatively frequently used group of excipients, are especially prone to physical instability. Through the process of physical ageing, a slow volume and enthalpy relaxation can be experienced, which can lead to remarkable alterations in solid dosage form properties. Functional changes within the solid dosage form associated with instability include changes in mechanical properties, homogeneity and drug release characteristics, discoloration, phase separation or changes in melting time of suppositories. Stability assessment is a crucial issue during formulation development, which is strictly regulated by authorities responsible for drug registration. The primary purpose of this paper is to give an overview of the different types of physical changes influencing solid state stability of dosage forms, and how such changes can be monitored. We will also illustrate how the quality of a solid dosage form varies with time under the influence of different environmental factors.

Original languageEnglish
Pages (from-to)5019-5028
Number of pages10
JournalCurrent Pharmaceutical Design
Volume22
Issue number32
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Dosage Forms
Excipients
Drug Stability
Pharmaceutical Preparations
Physical Phenomena
Suppositories
Product Packaging
Freezing
Polymers

Keywords

  • Macrostructural changes
  • Microstructural changes
  • Solid state changes
  • Solid state characterization
  • Stability

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

The role of solid state characterization in predicting stability of solid dosage forms. / Szabó, Péter; Zelkó, R.; Antal, I.

In: Current Pharmaceutical Design, Vol. 22, No. 32, 01.09.2016, p. 5019-5028.

Research output: Contribution to journalReview article

@article{55240da6cf4843e997605aba7bb129a4,
title = "The role of solid state characterization in predicting stability of solid dosage forms",
abstract = "Stability of a dosage form is its ability to preserve its quality attributes within preset limits. The time span over which these attributes remain within specifications is the shelf-life of the drug product. Stability is a very complex feature and is influenced not only by the stability of the drug substance but also by the stability of excipients and the interaction of the components within the system. Another important contributing factor is the packaging material, which is responsible for the protection of the drug product. Not only drug substances, but also excipients are susceptible to different degradation mechanisms. Amorphous polymers, a relatively frequently used group of excipients, are especially prone to physical instability. Through the process of physical ageing, a slow volume and enthalpy relaxation can be experienced, which can lead to remarkable alterations in solid dosage form properties. Functional changes within the solid dosage form associated with instability include changes in mechanical properties, homogeneity and drug release characteristics, discoloration, phase separation or changes in melting time of suppositories. Stability assessment is a crucial issue during formulation development, which is strictly regulated by authorities responsible for drug registration. The primary purpose of this paper is to give an overview of the different types of physical changes influencing solid state stability of dosage forms, and how such changes can be monitored. We will also illustrate how the quality of a solid dosage form varies with time under the influence of different environmental factors.",
keywords = "Macrostructural changes, Microstructural changes, Solid state changes, Solid state characterization, Stability",
author = "P{\'e}ter Szab{\'o} and R. Zelk{\'o} and I. Antal",
year = "2016",
month = "9",
day = "1",
doi = "10.2174/1381612822666160726094236",
language = "English",
volume = "22",
pages = "5019--5028",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "32",

}

TY - JOUR

T1 - The role of solid state characterization in predicting stability of solid dosage forms

AU - Szabó, Péter

AU - Zelkó, R.

AU - Antal, I.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Stability of a dosage form is its ability to preserve its quality attributes within preset limits. The time span over which these attributes remain within specifications is the shelf-life of the drug product. Stability is a very complex feature and is influenced not only by the stability of the drug substance but also by the stability of excipients and the interaction of the components within the system. Another important contributing factor is the packaging material, which is responsible for the protection of the drug product. Not only drug substances, but also excipients are susceptible to different degradation mechanisms. Amorphous polymers, a relatively frequently used group of excipients, are especially prone to physical instability. Through the process of physical ageing, a slow volume and enthalpy relaxation can be experienced, which can lead to remarkable alterations in solid dosage form properties. Functional changes within the solid dosage form associated with instability include changes in mechanical properties, homogeneity and drug release characteristics, discoloration, phase separation or changes in melting time of suppositories. Stability assessment is a crucial issue during formulation development, which is strictly regulated by authorities responsible for drug registration. The primary purpose of this paper is to give an overview of the different types of physical changes influencing solid state stability of dosage forms, and how such changes can be monitored. We will also illustrate how the quality of a solid dosage form varies with time under the influence of different environmental factors.

AB - Stability of a dosage form is its ability to preserve its quality attributes within preset limits. The time span over which these attributes remain within specifications is the shelf-life of the drug product. Stability is a very complex feature and is influenced not only by the stability of the drug substance but also by the stability of excipients and the interaction of the components within the system. Another important contributing factor is the packaging material, which is responsible for the protection of the drug product. Not only drug substances, but also excipients are susceptible to different degradation mechanisms. Amorphous polymers, a relatively frequently used group of excipients, are especially prone to physical instability. Through the process of physical ageing, a slow volume and enthalpy relaxation can be experienced, which can lead to remarkable alterations in solid dosage form properties. Functional changes within the solid dosage form associated with instability include changes in mechanical properties, homogeneity and drug release characteristics, discoloration, phase separation or changes in melting time of suppositories. Stability assessment is a crucial issue during formulation development, which is strictly regulated by authorities responsible for drug registration. The primary purpose of this paper is to give an overview of the different types of physical changes influencing solid state stability of dosage forms, and how such changes can be monitored. We will also illustrate how the quality of a solid dosage form varies with time under the influence of different environmental factors.

KW - Macrostructural changes

KW - Microstructural changes

KW - Solid state changes

KW - Solid state characterization

KW - Stability

UR - http://www.scopus.com/inward/record.url?scp=84995553663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995553663&partnerID=8YFLogxK

U2 - 10.2174/1381612822666160726094236

DO - 10.2174/1381612822666160726094236

M3 - Review article

VL - 22

SP - 5019

EP - 5028

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 32

ER -